Nervgen Pharma Corp (NGEN.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Operating Expenses | 4,147 | 3,667 | 2,767 | 2,230 | 4,414 |
| Operating Income | -4,147 | -3,667 | -2,767 | -2,230 | -4,414 |
| Other Income | 0 | 68 | 34 | -17 | -158 |
| Pre-tax Income | -4,147 | -3,599 | -2,733 | -2,247 | -4,572 |
| Net Income Continuous | -4,147 | -3,599 | -2,733 | -2,247 | -4,572 |
| Net Income | $-4,147 | $-3,599 | $-2,733 | $-2,247 | $-4,572 |
| EPS Basic Total Ops | -0.09 | -0.09 | -0.07 | -0.06 | -0.14 |
| EPS Basic Continuous Ops | -0.09 | -0.09 | -0.07 | -0.06 | -0.14 |
| EPS Diluted Total Ops | -0.09 | -0.09 | -0.07 | -0.06 | -0.14 |
| EPS Diluted Continuous Ops | -0.09 | -0.09 | -0.07 | -0.06 | -0.14 |
| EBITDA(a) | $-4,135 | $-3,656 | $-2,757 | $-2,220 | $-4,404 |